Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience

BİLGİN E., Ceylan F., DURAN E., Farisogullari B., BÖLEK E. Ç., YARDIMCI G. K., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.51, sa.1, ss.297-308, 2021 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 51 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.3906/sag-2007-123
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.297-308
  • Anahtar Kelimeler: Rheumatoid arthritis, tofacitinib, real-life, predictor, ACTIVE RHEUMATOID-ARTHRITIS, NECROSIS-FACTOR INHIBITORS, DISEASE-ACTIVITY, INADEQUATE RESPONSE, AMERICAN-COLLEGE, DRUG RETENTION, METHOTREXATE, ADALIMUMAB, CRITERIA, PLACEBO
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background/aim: To assess the real-life efficacy, retention rate, and safety data of tofacitinib in rheumatoid arthritis (RA) patients.